These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 30643010

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3.
    Xu E, Zhao J, Ma J, Wang C, Zhang C, Jiang H, Cheng J, Gao R, Zhou X.
    Oncol Rep; 2016 Jan; 35(1):275-83. PubMed ID: 26549292
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-340-5p inhibits the malignant phenotypes of osteosarcoma by directly targeting NRF2 and deactivating the PI3K/AKT pathway.
    Fan HP, Wang SY, Shi YY, Sun J.
    Eur Rev Med Pharmacol Sci; 2021 May; 25(10):3661-3669. PubMed ID: 34109575
    [Abstract] [Full Text] [Related]

  • 7. miR-485-5p/HSP90 axis blocks Akt1 phosphorylation to suppress osteosarcoma cell proliferation and migration via PI3K/AKT pathway.
    Liu Q, Wang Z, Zhou X, Tang M, Tan W, Sun T, Wang Y, Deng Y.
    J Physiol Biochem; 2020 May; 76(2):279-290. PubMed ID: 32100243
    [Abstract] [Full Text] [Related]

  • 8. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
    Song L, Zhou Z, Gan Y, Li P, Xu Y, Zhang Z, Luo F, Xu J, Zhou Q, Dai F.
    J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
    [Abstract] [Full Text] [Related]

  • 9. miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells.
    Luo Y, Liu W, Tang P, Jiang D, Gu C, Huang Y, Gong F, Rong Y, Qian D, Chen J, Zhou Z, Zhao S, Wang J, Xu T, Wei Y, Yin G, Fan J, Cai W.
    J Exp Clin Cancer Res; 2019 Dec 11; 38(1):488. PubMed ID: 31829261
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. miR-210-5p promotes epithelial-mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells.
    Liu W, Jiang D, Gong F, Huang Y, Luo Y, Rong Y, Wang J, Ge X, Ji C, Fan J, Cai W.
    Cell Death Dis; 2020 Feb 05; 11(2):93. PubMed ID: 32024814
    [Abstract] [Full Text] [Related]

  • 12. MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene.
    Pu Y, Zhao F, Wang H, Cai S.
    Sci Rep; 2017 Mar 10; 7():44218. PubMed ID: 28281638
    [Abstract] [Full Text] [Related]

  • 13. miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway.
    Yang G, Zhang C, Wang N, Chen J.
    Int J Biochem Cell Biol; 2019 Jun 10; 111():42-51. PubMed ID: 30986552
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. microRNA-524-5p inhibits proliferation and induces cell cycle arrest of osteosarcoma cells via targeting CDK6.
    Chen H, Cheng C, Gao S.
    Biochem Biophys Res Commun; 2020 Sep 24; 530(3):566-573. PubMed ID: 32747087
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1.
    Zhang Z, Zhang W, Mao J, Xu Z, Fan M.
    Cell Physiol Biochem; 2019 Sep 24; 52(3):553-564. PubMed ID: 30897321
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MicroRNA-191-5p promotes the development of osteosarcoma via targeting EGR1 and activating the PI3K/AKT signaling pathway.
    Chen B, Zheng ZY, Yang JZ, Li XG.
    Eur Rev Med Pharmacol Sci; 2019 May 24; 23(9):3611-3620. PubMed ID: 31114985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.